CYTK
Price
$50.26
Change
-$0.86 (-1.68%)
Updated
Feb 21 closing price
Capitalization
5.93B
4 days until earnings call
IKT
Price
$2.97
Change
-$0.29 (-8.90%)
Updated
Feb 21 closing price
Capitalization
206.01M
Ad is loading...

CYTK vs IKT

Header iconCYTK vs IKT Comparison
Open Charts CYTK vs IKTBanner chart's image
Cytokinetics
Price$50.26
Change-$0.86 (-1.68%)
Volume$2.17M
Capitalization5.93B
Inhibikase Therapeutics
Price$2.97
Change-$0.29 (-8.90%)
Volume$266.76K
Capitalization206.01M
CYTK vs IKT Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. IKT commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and IKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CYTK: $50.26 vs. IKT: $2.97)
Brand notoriety: CYTK and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 140% vs. IKT: 105%
Market capitalization -- CYTK: $5.93B vs. IKT: $206.01M
CYTK [@Biotechnology] is valued at $5.93B. IKT’s [@Biotechnology] market capitalization is $206.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileIKT’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • IKT’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than IKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 6 TA indicator(s) are bullish while IKT’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 6 bullish, 4 bearish.
  • IKT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than IKT.

Price Growth

CYTK (@Biotechnology) experienced а +8.88% price change this week, while IKT (@Biotechnology) price change was +26.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

CYTK is expected to report earnings on May 07, 2025.

IKT is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.93B) has a higher market cap than IKT($206M). CYTK YTD gains are higher at: 6.845 vs. IKT (-8.615). IKT has higher annual earnings (EBITDA): -20.04M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. IKT (3.24M). IKT has less debt than CYTK: IKT (145K) vs CYTK (790M). CYTK has higher revenues than IKT: CYTK (3.22M) vs IKT (0).
CYTKIKTCYTK / IKT
Capitalization5.93B206M2,879%
EBITDA-481.94M-20.04M2,405%
Gain YTD6.845-8.615-79%
P/E RatioN/AN/A-
Revenue3.22M0-
Total Cash1.01B3.24M31,196%
Total Debt790M145K544,828%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
52
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKIKT
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMIEX11.68N/A
N/A
Northern Active M International Equity
SSAIX11.68N/A
N/A
State Street International Stock Sel N
GSPCX13.96N/A
N/A
Goldman Sachs Large Cap Core C
RBCRX10.08N/A
N/A
RBC China Equity R6
HMDFX28.35N/A
N/A
Hartford MidCap F

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with TRDA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-1.68%
TRDA - CYTK
44%
Loosely correlated
-0.23%
KRON - CYTK
43%
Loosely correlated
-1.96%
DARE - CYTK
42%
Loosely correlated
+0.32%
ACLX - CYTK
41%
Loosely correlated
-2.83%
CGEN - CYTK
39%
Loosely correlated
-3.67%
More